Stress Hormones, Mood and Women's Sexual Desire (MODEST) (MODEST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01702818 |
Recruitment Status :
Completed
First Posted : October 8, 2012
Last Update Posted : October 17, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hypoactive Sexual Desire Disorder (HSDD) |
Study Type : | Observational |
Actual Enrollment : | 324 participants |
Observational Model: | Other |
Time Perspective: | Cross-Sectional |
Official Title: | Stress Hormones, Mood and Women's Sexual Desire (MODEST) |
Study Start Date : | February 2012 |
Actual Primary Completion Date : | November 2016 |
Actual Study Completion Date : | November 2016 |
Group/Cohort |
---|
HSDD group
Women with a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).
|
Control Group
Women without a diagnosis of Hypoactive Sexual Desire Disorder (HSDD).
|
- DHEA levels [ Time Frame: Data is collected at 4 time points on 3 separate days ]DHEA levels derived from saliva samples.
- Cortisol levels [ Time Frame: Data is collected at 4 time points on 3 separate days ]Cortisol levels derived from saliva samples.
- Depression [ Time Frame: data is collected at single time point ]Depression will be measured by the Beck Depression Inventory (Beck & Beamesderfer, 1974)
- Perceived stress [ Time Frame: data is collected at a single time point ]Perceived stress will be measured with the 10-item Perceived Stress Scale (Roberti, Harrington & Storch 2006)
- Sexual function [ Time Frame: data is collected at a single time point ]Self-report sexual function will be measured with the Sexual Interest and Desire Inventory (Clayton et al. 2006))
- Relationship satisfaction [ Time Frame: data is collected at a single time point ]Relationship satisfaction will be measured with the Relationship Assessment Scale (Hendrick, 1988) and the Dyadic Adjustment Scale (Spanier, 1976)
- History of childhood trauma [ Time Frame: dat is collected at a single timepoint ]History of childhood trauma will be determined with the Childhood Trauma Questionnaire (Bernstein & Fink, 1995)
- History of childhood sexual abuse [ Time Frame: data is collected at a single time point ]History of Childhood Sexual Abuse will be determined with the Childhood Sexual Abuse Measure (Finkelhor, 1979)
- PTSD symptoms [ Time Frame: data is collected at a single time point ]Presence and severity of post traumatic stress disorder symptoms will be determined through the Clinician-Administered PTSD Scale (Blake et al. 1998)
Biospecimen Retention: Samples Without DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria for HSDD Group:
- (1) diagnosis of HSDD
- (2) over 19 years of age
- (3) sexual complaints of low desire of at least 12 months duration.
Inclusion criteria for Control group:
- (1) sexually healthy, i.e., must not meet criteria for any sexual dysfunction, as determined by a telephone screening, followed by an in-person structured assessment, the Decreased Sexual Desire Screener (DSDS)
- (2) over 19 years of age.
Exclusion Criteria for both Control and HSDD groups:
- (1) lack of fluency in English
- (2) currently meeting DSM-IV-TR diagnostic criteria for major depressive disorder as measured by an in-person, semi-structured interview based on the Major Depressive Disorder Module of the Structured Clinical Interview for DSM-IV-TR (SCID-I
- (3) current use of prescription drugs such as antidepressants or other medications with known sexual side effects (e.g., glucocorticoids, aromatase inhibitors), or known effects on cortisol metabolism, or use of illicit drugs
- (4) use of hormone replacement therapy or hormonal contraceptives;
- (5) a body mass index (BMI) <18.5 or >29.9
- (6) cigarette smoking
- (7) chronic medical or psychiatric disease with potential to interfere with sexual function (e.g., chronic neurological disease, cardiac and liver disease, eating disorders, anxiety disorders)
- (8) chronic pain with intercourse not relieved by a vaginal lubricant
- (9) loss of genital responsiveness
- (10) significant relationship discord
- (11) not having a family physician who we could contact if depression is diagnosed during the assessment
- (12) difficulty in complying with questionnaires or in completing interview.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01702818
Canada, British Columbia | |
British Columbia Centre for Sexual Medicine | |
Vancouver, British Columbia, Canada, V6T 1Z9 |
Principal Investigator: | Rosemary Basson, MD | University of British Columbia | |
Principal Investigator: | Lori A Brotto, PhD | University of British Columbia |
Responsible Party: | Lori Brotto, Associate Professor, University of British Columbia |
ClinicalTrials.gov Identifier: | NCT01702818 |
Other Study ID Numbers: |
H10-02067 |
First Posted: | October 8, 2012 Key Record Dates |
Last Update Posted: | October 17, 2018 |
Last Verified: | May 2017 |
Hypoactive Sexual Desire Disorder HSDD Cortisol DHEA Stress Hormones |
Sexual Desire Mood Sexual Function Childhood Maltreatment Childhood Abuse |
Hypokinesia Sexual Dysfunctions, Psychological Dyskinesias |
Neurologic Manifestations Nervous System Diseases Mental Disorders |